193 related articles for article (PubMed ID: 15104374)
1. Adefovir dipivoxil as a treatment for hepatic failure caused by lamivudine-resistant HBV strains.
Kuwahara R; Kumashiro R; Inoue H; Tanabe R; Tanaka E; Hino T; Ide T; Koga Y; Sata M
Dig Dis Sci; 2004 Feb; 49(2):300-3. PubMed ID: 15104374
[No Abstract] [Full Text] [Related]
2. Severe exacerbation of chronic hepatitis B after emergence of lamivudine resistance in a cirrhotic patient: immediate switch to adefovir dipivoxil appears to be indicated.
Wiegand J; Tischendorf JJ; Nashan B; Klempnauer J; Flemming P; Niemann P; Rohde P; Manns MP; Trautwein C; Tillmann HL
Z Gastroenterol; 2004 Jan; 42(1):15-8. PubMed ID: 14997399
[TBL] [Abstract][Full Text] [Related]
3. Liver transplantation for chronic hepatitis B with lamivudine-resistant YMDD mutant using add-on adefovir dipivoxil plus lamivudine.
Lo CM; Liu CL; Lau GK; Chan SC; Ng IO; Fan ST
Liver Transpl; 2005 Jul; 11(7):807-813. PubMed ID: 15973721
[TBL] [Abstract][Full Text] [Related]
4. Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B.
Peters MG; Hann Hw Hw; Martin P; Heathcote EJ; Buggisch P; Rubin R; Bourliere M; Kowdley K; Trepo C; Gray Df Df; Sullivan M; Kleber K; Ebrahimi R; Xiong S; Brosgart CL
Gastroenterology; 2004 Jan; 126(1):91-101. PubMed ID: 14699491
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus kinetics and mathematical modeling.
Perelson AS; Ribeiro RM
Semin Liver Dis; 2004; 24 Suppl 1():11-6. PubMed ID: 15192796
[TBL] [Abstract][Full Text] [Related]
6. Long-term adefovir dipivoxil monotherapy for up to 5 years in lamivudine-resistant chronic hepatitis B.
Lee JM; Park JY; Kim DY; Nguyen T; Hong SP; Kim SO; Chon CY; Han KH; Ahn SH
Antivir Ther; 2010; 15(2):235-41. PubMed ID: 20386079
[TBL] [Abstract][Full Text] [Related]
7. Adefovir-lamivudine combination therapy and hepatitis B viral kinetics.
Mutimer D
J Hepatol; 2005 Aug; 43(2):200-2. PubMed ID: 15975684
[No Abstract] [Full Text] [Related]
8. Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus.
Perrillo R; Hann HW; Mutimer D; Willems B; Leung N; Lee WM; Moorat A; Gardner S; Woessner M; Bourne E; Brosgart CL; Schiff E
Gastroenterology; 2004 Jan; 126(1):81-90. PubMed ID: 14699490
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study.
Benhamou Y; Bochet M; Thibault V; Calvez V; Fievet MH; Vig P; Gibbs CS; Brosgart C; Fry J; Namini H; Katlama C; Poynard T
Lancet; 2001 Sep; 358(9283):718-23. PubMed ID: 11551579
[TBL] [Abstract][Full Text] [Related]
10. [Lamivudine and adefovir dipivoxil combination treatment for liver cirrhosis patients with CHB].
Yang DH; Xie SF; Wang YM; Zhao NF; Li MW
Zhonghua Gan Zang Bing Za Zhi; 2008 Jun; 16(6):473-4. PubMed ID: 18579006
[No Abstract] [Full Text] [Related]
11. Adefovir dipivoxil to prevent exacerbation of lamivudine-resistant hepatitis B infection during chemotherapy for non-Hodgkin's lymphoma.
Enomoto M; Nishiguchi S; Seki S; Yamane T; Hino M
Am J Gastroenterol; 2004 Aug; 99(8):1619-20. PubMed ID: 15307884
[No Abstract] [Full Text] [Related]
12. Dynamics of lamivudine-resistant hepatitis B virus during adefovir monotherapy versus lamivudine plus adefovir combination therapy.
Ijaz S; Arnold C; Dervisevic S; Mechurova J; Tatman N; Tedder RS; Naoumov NV
J Med Virol; 2008 Jul; 80(7):1160-70. PubMed ID: 18461609
[TBL] [Abstract][Full Text] [Related]
13. Fulminant hepatic failure resulting from lamivudine-resistant hepatitis B virus in a renal transplant recipient: durable response after orthotopic liver transplantation on adefovir dipivoxil and hepatitis B immune globulin.
Peters MG; Singer G; Howard T; Jacobsmeyer S; Xiong X; Gibbs CS; Lamy P; Murray A
Transplantation; 1999 Dec; 68(12):1912-4. PubMed ID: 10628774
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of fibrosing cholestatic hepatitis using adefovir dipivoxil in a patient with cirrhosis and renal insufficiency.
Tillmann HL; Bock CT; Bleck JS; Rosenau J; Böker KH; Barg-Hock H; Becker T; Trautwein C; Klempnauer J; Flemming P; Manns MP
Liver Transpl; 2003 Feb; 9(2):191-6. PubMed ID: 12548514
[TBL] [Abstract][Full Text] [Related]
15. Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy.
van Bömmel F; Zöllner B; Sarrazin C; Spengler U; Hüppe D; Möller B; Feucht HH; Wiedenmann B; Berg T
Hepatology; 2006 Aug; 44(2):318-25. PubMed ID: 16871563
[TBL] [Abstract][Full Text] [Related]
16. [A case of liver cirrhosis B resistant to lamivudine showing the clinical effect of adefovir dipivoxil].
Sumida Y; Kanemasa K; Tachibana S; Maekawa K; Mori K; Minami M; Okanoue T
Nihon Shokakibyo Gakkai Zasshi; 2004 May; 101(5):521-4. PubMed ID: 15168763
[No Abstract] [Full Text] [Related]
17. A novel pattern (sW195a) in surface gene of HBV DNA due to YSDD (L180M plus M204S) mutation selected during lamivudine therapy and successful treatment with adefovir dipivoxil.
Bozdayi AM; Eyigun CP; Turkyilmaz AR; Avci IY; Pahsa A; Yurdaydin C
J Clin Virol; 2004 Sep; 31(1):76-7. PubMed ID: 15288618
[No Abstract] [Full Text] [Related]
18. Adefovir dipivoxil therapy in liver transplant recipients with lamivudine-resistant hepatitis B virus.
Herreros de Tejada Echanojáuregui A; Moreno Planas JM; Rubio González E; Portero Azorin F; López Monclús J; Revilla Negro J; Lucena de la Poza JL; Sánchez Turrión V; Barrios Peinado C; Cuervas-Mons Martínez V
Transplant Proc; 2005 Apr; 37(3):1507-8. PubMed ID: 15866657
[TBL] [Abstract][Full Text] [Related]
19. Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis B.
Dai CY; Chuang WL; Hsieh MY; Lee LP; Huang JF; Hou NJ; Lin ZY; Chen SC; Hsieh MY; Wang LY; Tsai JF; Chang WY; Yu ML
Antiviral Res; 2007 Aug; 75(2):146-51. PubMed ID: 17400303
[TBL] [Abstract][Full Text] [Related]
20. Long-term therapy with adefovir dipivoxil in hepatitis B e antigen-negative patients developing resistance to lamivudine.
Manolakopoulos S; Bethanis S; Koutsounas S; Goulis J; Vlachogiannakos J; Christias E; Saveriadis A; Pavlidis C; Triantos C; Christidou A; Papatheodoridis G; Karamanolis D; Tzourmakliotis D
Aliment Pharmacol Ther; 2008 Feb; 27(3):266-73. PubMed ID: 17988233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]